A new regional angel fund has been launched called Mass Medical Angels, devoted exclusively to backing life sciences startups. Mass Medical Angels (MA2), according to its one-page website, plans to fund early stage biotechs that want to raise from $250,000 to $3 million. As the site notes, “The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community.”
